COLRF (Tian An Medicare) Research & Development: $0.0 Mil (TTM As of Dec. 2025)


COLRF Tian An Medicare Ltd COLRF
36 GF Score
Price $0.08
GF Value $0.07
! 4 Warning Signs
View Full Analysis

What is Tian An Medicare Research & Development?

Tian An Medicare COLRF 36 Research & Development is $0.0 Mil as of Dec. 2025. GuruFocus rates COLRF with a GF Score™ of 36/100 and a GF Value™ of $0.07. The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Tian An Medicare's Research & Development for the six months ended in Dec. 2025 was $0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was $0.0 Mil.

Tian An Medicare  (OTCPK:COLRF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Tian An Medicare Research & Development Related Terms

Tian An Medicare Research & Development Historical Data

* Premium members only.

The historical data trend for Tian An Medicare's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tian An Medicare Research & Development Chart

Tian An Medicare Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Tian An Medicare Semi-Annual Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
COLRF
36GF Score
Tian An Medicare Ltd COLRF
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tian An Medicare Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.0 Mil mean?
Tian An Medicare (COLRF) has a Research & Development of $0.0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Tian An Medicare and its competitors.
Is Tian An Medicare's Research & Development too high?
Tian An Medicare's current Research & Development is $0.0 Mil. Overall, Tian An Medicare has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does Tian An Medicare's Research & Development compare to HCA and THC?
Tian An Medicare's Research & Development of $0.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Tian An Medicare and its competitors. Tian An Medicare's current Research & Development is $0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tian An Medicare stock overvalued right now?
Tian An Medicare (COLRF) has a current Research & Development of $0.0 Mil. The stock's GF Value™ is $0.07, compared to a current price of $0.08 — trading 14.3% above its estimated fair value. The current Research & Development is $0.0 Mil. Tian An Medicare's overall GF Score™ is 36/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Tian An Medicare (COLRF), the current Research & Development is $0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tian An Medicare (COLRF) Overvalued in 2026?

Based on GuruFocus' analysis, Tian An Medicare stock appears to be overvalued. The current stock price of $0.08 is trading 14.3% above its estimated GF Value™ of $0.07.

Key valuation signals for COLRF:

  • Research & Development: $0.0 Mil
  • GF Value™: $0.07 vs. price of $0.08 (14.3% above fair value)
  • GF Score™: 36/100 with 4 warning signs

No single metric tells the full story. See the COLRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tian An Medicare Business Description

Other Exchanges 00383:Hong KongSMI:Germany
Address No. 138 Gloucester Road, Rooms 1904B-5, 19th Floor, Allied Kajima Building, Wanchai, Hong Kong, HKG
Tian An Medicare Ltd is an investment holding company and operator of integrated healthcare and eldercare services. Its main focus is on the investment, management and operations of healthcare and eldercare businesses, and the related property investment and development, and comprehensive spectrum of healthcare and eldercare services to customers in the People's Republic of China (PRC) and Asia Pacific. The Group is also involved in businesses of securities trading and investment, and provision of financial services. Its segments includes: Healthcare; Eldercare; and Property Development, of which it derives maximum revenue from Healthcare segment.
36GF Score

Get the complete analysis for COLRF

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.08
Price
$0.07
GF Value